Short Description

Vast majority of cases of Acute Promyelocytic Leukemia (APL) have a translocation t(1517)(q22q12-21) which fuses the Promyelocytic gene (PML) on chromosome band 15q22 to the Retinoic acid receptor alpha (RARA) gene at 17q12-21. This assay is useful for montoring patients in which t(1517) (q22q12) has been detected.

PreTest Information

Duly filled MRD Requisition form (Form 22) with historical data is mandatory.

Detail Description

PML RARA t(1517)(q22q12) Gene Rearrangement Quantitative MRD Monitor Test Cost INR:6084 Symptoms Diagnosis

As we all know, cancer is a deadly disease that has been claiming lives for decades. However, with the advancement of technology and medical science, we have been able to fight cancer in a better way. DNA Labs India is proud to introduce the PML RARA t(1517)(q22q12) Gene Rearrangement Quantitative MRD Monitor Test which can help diagnose and monitor leukemia.

Symptoms of PML RARA t(1517)(q22q12) Gene Rearrangement

The symptoms of PML RARA t(1517)(q22q12) Gene Rearrangement can vary from person to person. However, some of the common symptoms include:

• Fever
• Fatigue
• Loss of appetite
• Weight loss
• Bruising or bleeding easily
• Swollen lymph nodes
• Bone pain
• Shortness of breath

If you experience any of these symptoms, it is important to seek medical attention immediately.

Diagnosis of PML RARA t(1517)(q22q12) Gene Rearrangement

Diagnosing PML RARA t(1517)(q22q12) Gene Rearrangement can be challenging, as the symptoms can be similar to other diseases. However, there are certain tests that can help diagnose this condition, including:

• Complete blood count (CBC)
• Bone marrow biopsy
• Flow cytometry
• Cytogenetic analysis

PML RARA t(1517)(q22q12) Gene Rearrangement Quantitative MRD Monitor Test

The PML RARA t(1517)(q22q12) Gene Rearrangement Quantitative MRD Monitor Test is a highly specialized test that helps diagnose and monitor leukemia. It is a molecular test that detects the presence of the PML RARA gene rearrangement at a molecular level.

This test is performed using a small sample of blood or bone marrow. The sample is sent to the laboratory for analysis, and the results are usually available within a few days.

Test Cost

The cost of the PML RARA t(1517)(q22q12) Gene Rearrangement Quantitative MRD Monitor Test is INR 6084.

Conclusion

The PML RARA t(1517)(q22q12) Gene Rearrangement Quantitative MRD Monitor Test is an important tool in the diagnosis and monitoring of leukemia. It is a highly specialized test that can help detect the presence of the PML RARA gene rearrangement at a molecular level. If you experience any of the symptoms of PML RARA t(1517)(q22q12) Gene Rearrangement, it is important to seek medical attention immediately.